A seven-membered oxygen-bridged ring compound and its preparation method
The method of constructing seven-membered oxygen-bridged ring compounds in the visible light using a solvent red catalyst solves the problems of cumbersome synthesis steps, high cost, and poor selectivity in existing technologies. It achieves a green synthesis that is free of metal residues, mild, efficient, and suitable for the preparation of pharmaceutical intermediates.
Patent Information
- Application Number
- CN202611253673.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-18
- Publication Date
- 2026-11-17
AI Technical Summary
Existing methods for synthesizing seven-membered oxygen-bridged ring compounds suffer from problems such as lengthy traditional stepwise cyclization steps, low atom economy, complex separation and purification, high cost of transition metal catalytic routes, difficulty in removing metal residues, poor selectivity, narrow substrate applicability of photocatalytic systems, and poor selectivity.
The visible light catalysis method was adopted, using Solvent Red as the photocatalyst. The reaction was carried out under visible light irradiation, and a seven-membered oxygen-bridged ring compound was constructed in one step through intramolecular radical cyclization of the seven-membered ring substrate. The use of transition metal catalysts was avoided. Alkali promoters such as K2CO3, Cs2CO3, Na2CO3 or CsF were selected, and reaction solvents such as N,N-dimethylformamide, N,N-dimethylacetamide, dimethyl sulfoxide or acetonitrile were used. Column chromatography was used to separate the products.
It achieves metal-free, mild, and green synthesis, improves the selectivity and efficiency of synthesis, simplifies the operation process, is suitable for the preparation of pharmaceutical intermediates, and reduces costs.
Smart Images

Figure CN123106697A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of organic synthesis and photocatalysis technology, specifically relating to a seven-membered oxygen-bridged ring compound and its preparation method. Background Technology
[0002] Seven-membered oxygen-bridged rings are the core framework of many active natural products, drug molecules and functional materials. They have key application value in the development of anti-inflammatory, anti-tumor and antibacterial drugs and the synthesis of fine chemicals. Their efficient and green construction has always been a research focus in the field of organic synthesis.
[0003] Existing synthetic methods suffer from significant drawbacks: traditional stepwise cyclization steps are lengthy, have low atom economy, and are complex to separate and purify; while transition metal catalytic routes simplify the process, they rely on precious metals such as palladium, rhodium, and ruthenium, along with specialized ligands, requiring strong oxidation / reduction or high-temperature, high-pressure conditions, resulting in high costs, difficulty in removing metal residues, poor selectivity, and limitations in applications such as medicine. Furthermore, existing photocatalytic systems still suffer from a narrow substrate applicability and poor selectivity, thus requiring improvement. Summary of the Invention
[0004] One objective of this invention is to provide a method for preparing a seven-membered oxygen-bridged ring compound, the reaction process of which is shown in formula (I). (I) Wherein, R1 is hydrogen, methoxy, nitro, bromine or methyl; R2 is hydrogen, chlorine, fluorine or methyl; The preparation method includes the following steps: Step 1: Add the seven-membered ring substrate, Solvent Red catalyst, and base auxiliary agent to the reaction vessel, and add the reaction solvent to the reaction system to dissolve the reactants; Step 2: The reaction system is stirred under visible light irradiation; Step 3: After the reaction is complete, the reaction solution is concentrated and separated by column chromatography to obtain the seven-membered oxygen-bridged ring product.
[0005] As a preferred embodiment, the seven-membered ring substrate is a seven-membered ring with an electron-withdrawing group or a seven-membered ring with an electron-donating group.
[0006] As a preferred embodiment, the alkali additive is one of K2CO3, Cs2CO3, Na2CO3 or CsF.
[0007] As a preferred embodiment, the reaction solvent is one of N,N-dimethylformamide, N,N-dimethylacetamide, dimethyl sulfoxide, or acetonitrile.
[0008] As a preferred embodiment, the molar ratio of seven-membered ring substrate: base promoter: solvent red catalyst is 1:(0.5~2):0.05.
[0009] As a preferred embodiment, in step two, a 455 nm blue LED is used for irradiation.
[0010] The second objective of this invention is to provide a seven-membered oxygen-bridged ring compound, the structural formula of which is shown in formula (II) below:
[0011] (II) Wherein, R1 is hydrogen, methoxy, nitro, bromine or methyl; R2 is hydrogen, chlorine, fluorine or methyl.
[0012] As a preferred option, its structure is as follows: ; ; ; ; ; ; ; ; ; ; .
[0013] The preparation method of this invention overcomes the shortcomings of existing technologies, such as metal residue, high cost, harsh conditions, and poor selectivity. Visible light photocatalysis offers advantages such as mildness, greenness, and high selectivity, providing a new direction for cyclic framework construction. Solvent Red, as a commercially available organic dye, exhibits excellent visible light absorption and redox properties, making it suitable as a metal-free photocatalyst, meeting the requirements of green synthesis. This invention does not use any transition metal catalysts, transition metal salts, or transition metal complexes, effectively avoiding metal residue and making it more suitable for the preparation of pharmaceutical intermediates, truly achieving green, mild, and efficient synthesis.
[0014] The possible reaction mechanism is speculated to be as follows: Solvent red is converted to an excited state under light irradiation. Starting material 1 (substrate of formula I) undergoes electron transfer to generate radical intermediate 2. Intermediate 2 undergoes radical cyclization to generate oxygen-bridged ring intermediate 3, which is then oxidized to carbide intermediate 4. Finally, nucleophilic attack occurs to give the target product 5 (product of formula II). The reaction mechanism is as follows:
[0015] The present invention has the following beneficial effects: This invention provides a green synthesis method for seven-membered oxygen-bridged rings that is mild, highly selective, and free of metal residues through process optimization. It effectively solves the problems of cumbersome steps, poor atom economy, high cost, and metal residues, and has significant scientific and industrial value for expanding the synthetic pathways of this type of molecule and promoting its application in the fields of medicine and materials. The raw materials prepared by this method are free of transition metals. Using Solvent Red dye as a photocatalyst, it efficiently constructs seven-membered oxygen-bridged ring compounds under visible light irradiation. The seven-membered ring substrate undergoes intramolecular radical cyclization to construct the seven-membered oxygen-bridged ring structure in one step. The advantages are as follows: 1. Transition metal-free system: No transition metal catalysts, transition metal salts, or transition metal complexes are used, resulting in no metal residues, making it particularly suitable for the synthesis of pharmaceutical intermediates. 2. Inexpensive and readily available catalyst: Commercially available Solvent Red is used, which is low in cost, low in toxicity, and easy to store. 3. Mild conditions: Room temperature, visible light, no high temperature or high pressure required. 4. Green and environmentally friendly: High atom economy, simple operation, and convenient post-processing. The resulting seven-membered oxygen-bridged ring compound obtained by this method has potential application value in the fields of natural product synthesis, drug intermediates, biological probes, and photocatalytic materials. Attached Figure Description
[0016] Figure 1 The 1H NMR spectra of products 1-5a are shown (400 MHz, CDCl3). Figure 2 Carbon spectra of products 1-5a (100 MHz, CDCl3); Figure 3 The 1H NMR spectra of products 1-5b are shown (400 MHz, CDCl3). Figure 4 The carbon spectra of products 1-5b are shown (100 MHz, CDCl3). Figure 5 The hydrogen spectral density (H2N) spectra of products 1-5c are shown (400 MHz, CDCl3). Figure 6 The carbon spectra of product 1-5c are shown (100 MHz, CDCl3). Figure 7 The 1H NMR spectrum of the product from day 1 to 5 (400 MHz, CDCl3); Figure 8 The carbon spectra of the product from day 1 to 5 are shown (100 MHz, CDCl3). Figure 9 The 1H NMR spectrum of product 1-5e is shown (400 MHz, CDCl3). Figure 10 The carbon spectra of product 1-5e are shown (100 MHz, CDCl3). Figure 11 The 1H NMR spectra of products 1-5f are shown (400 MHz, CDCl3). Figure 12 The carbon spectra of the product from 1 to 5f are shown (100 MHz, CDCl3). Figure 13 The 1H NMR spectrum of product 1-5g is shown (400 MHz, CDCl3). Figure 14 Carbon spectra of products 1-5g (100 MHz, CDCl3); Figure 15 The 1H NMR spectrum of the product is shown at 1-5 hours (400 MHz, CDCl3). Figure 16 The carbon spectra of the product from 1 to 5 hours are shown (100 MHz, CDCl3). Figure 17 The proton NMR spectra of products 1-5i are shown (400 MHz, CDCl3). Figure 18 Carbon spectra of products 1-5i (100 MHz, CDCl3); Figure 19 The 1H NMR spectra of products 1-5j are shown (400 MHz, CDCl3). Figure 20 The carbon spectra of products 1-5j are shown (100 MHz, CDCl3). Figure 21 The 1H NMR spectrum of the product at 1-5K (400 MHz, CDCl3); Figure 22 The carbon spectra of the product from 1 to 5 k is shown (100 MHz, CDCl3). Figure 23 This is a schematic diagram of the single-crystal X-ray diffraction structure of compounds 1-5a. Detailed Implementation
[0017] To make the technical means, creative features, objectives, and beneficial effects of this invention easier to understand, the invention will be further described below in conjunction with specific embodiments.
[0018] In addition, to better illustrate the present invention, numerous specific details are given in the following detailed embodiments. Those skilled in the art should understand that the present invention can be implemented even without certain specific details. In other embodiments, methods, means, equipment and steps well known to those skilled in the art are not described in detail in order to highlight the main points of the present invention.
[0019] The present invention provides a method for preparing a seven-membered oxygen-bridged ring compound, comprising the following preparation steps: Using a dry reaction tube as the reaction apparatus, a seven-membered ring substrate is first added, followed by Solvent Red catalyst and a base auxiliary agent. The base auxiliary agent can be one of K₂CO₃, Cs₂CO₃, Na₂CO₃, or CsF, preferably Na₂CO₃. Next, a dry reaction solvent is added, which is one of N,N-dimethylformamide, N,N-dimethylacetamide, dimethyl sulfoxide, or acetonitrile, preferably acetonitrile. After the addition is complete, the reaction is stirred at room temperature under blue light for 4-12 hours, preferably 12 hours. After the reaction is complete, the mixture is rotary evaporated, and the purified product is obtained by column chromatography. The molar ratio of seven-membered ring substrate: sodium carbonate: Solvent Red is 1:(0.5-2):0.05.
[0020] Unless otherwise specified, Et in this article refers to the ethyl group.
[0021] Example 1
[0022] Synthesis of 1-5a: Synthesis of ethyl(5R)-6-benzoyl-5-hydroxy-7-phenyl-8-oxabicyclo[3.2.1]oct-6-ene-1-carboxylic acid ester.
[0023] (1-5a) A seven-membered ring substrate (0.2 mmol), Solvent Red 43 (0.01 mmol, 5%), sodium carbonate (0.2 mmol), and anhydrous acetonitrile (2 mL) were added to a dry reaction tube. The reaction was irradiated with a 455 nm blue light (250 V, 4 A) LED and stirred at room temperature (20-25 °C) for 12 h. After the reaction was complete as monitored by TLC, the solvent was removed by rotary evaporation under reduced pressure. The crude product was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 5:1, V / V) to obtain 59.1 mg of the seven-membered oxygen-bridged ring product, with a separation yield of 78%.
[0024] NMR data: 1 H NMR (400 MHz, CDCl3) δ 1.15-1.19 (t, J = 8 Hz, 3H), 1.62-1.69 (m, 4H), 1.84-1.86 (m, 1H), 2.01-2.04 (m, 1H), 4.18-4.26 (m, 2H), 6.94-6.97 (m, 2H), 7.16-7.19 (m, 2H), 7.31-7.35 (m, 2H), 7.44-7.48 (m, 2H), 7.71-7.73 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 194.2, 169.5, 145.8, 141.2, 136.7,133.8, 131.2, 129.6, 129.3, 128.8, 128.7, 128.3, 109.6, 88.2, 61.7, 30.8,25.4, 19.0, 14.4. Single-crystal X-ray diffraction tests were performed on compounds 1-5a obtained in Example 1. The single-crystal analysis results showed that the absolute configuration of the chiral carbon atom at the C5 position of this compound was (5R). The other substituent derivatives of this invention were all prepared under the same reaction conditions as in this example. The stereoinduction reaction may be consistent, and the preferred configuration of the obtained products is (5R).
[0025] Example 2
[0026] Synthesis of 1-5a: Synthesis of ethyl(5R)-6-benzoyl-5-hydroxy-7-phenyl-8-oxabicyclo[3.2.1]oct-6-ene-1-carboxylic acid ester.
[0027] (1-5a) A seven-membered ring substrate (0.2 mmol), Solvent Red 43 (0.01 mmol, 5%), potassium carbonate (0.2 mmol), and anhydrous acetonitrile (2 mL) were added to a dry reaction tube. The reaction was irradiated with a 455 nm blue light (250 V, 4 A) LED and stirred at room temperature (20-25 °C) for 12 h. After the reaction was complete as monitored by TLC, the solvent was removed by rotary evaporation under reduced pressure. The crude product was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 5:1, V / V) to obtain 49.9 mg of the seven-membered oxygen-bridged ring product, with a separation yield of 66%.
[0028] Example 3
[0029] Synthesis of 1-5a: Synthesis of ethyl(5R)-6-benzoyl-5-hydroxy-7-phenyl-8-oxabicyclo[3.2.1]oct-6-ene-1-carboxylic acid ester.
[0030]
[0031] (1-5a) A seven-membered ring substrate (0.2 mmol), Solvent Red 43 (0.01 mmol, 5%), cesium carbonate (0.2 mmol), and anhydrous acetonitrile (2 mL) were added to a dry reaction tube. The reaction was irradiated with a 455 nm blue light (250 V, 4 A) LED and stirred at room temperature (20-25 °C) for 12 h. After the reaction was complete as monitored by TLC, the solvent was removed by rotary evaporation under reduced pressure. The crude product was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 5:1, V / V) to obtain 40.1 mg of the seven-membered oxygen-bridged ring product, with a separation yield of 53%.
[0032] Example 4
[0033] Synthesis of 1-5a: Synthesis of ethyl(5R)-6-benzoyl-5-hydroxy-7-phenyl-8-oxabicyclo[3.2.1]oct-6-ene-1-carboxylic acid ester.
[0034] (1-5a) A seven-membered ring substrate (0.2 mmol), Solvent Red 43 (0.01 mmol, 5%), cesium fluoride (0.2 mmol), and anhydrous acetonitrile (2 mL) were added to a dry reaction tube. The reaction was irradiated with a 455 nm blue light (250 V, 4 A) LED and stirred at room temperature (20-25 °C) for 12 h. After the reaction was complete as monitored by TLC, the solvent was removed by rotary evaporation under reduced pressure. The crude product was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 5:1, V / V) to obtain 35.6 mg of the seven-membered oxygen-bridged ring product, with a separation yield of 47%.
[0035] Example 5
[0036] Synthesis of 1-5a: Synthesis of ethyl(5R)-6-benzoyl-5-hydroxy-7-phenyl-8-oxabicyclo[3.2.1]oct-6-ene-1-carboxylic acid ester.
[0037]
[0038] (1-5a) A seven-membered ring substrate (0.2 mmol), Solvent Red 43 (0.01 mmol, 5%), sodium carbonate (0.4 mmol), and anhydrous acetonitrile (2 mL) were added to a dry reaction tube. The reaction was irradiated with a 455 nm blue light (250 V, 4 A) LED and stirred at room temperature (20-25 °C) for 12 h. After the reaction was complete as monitored by TLC, the solvent was removed by rotary evaporation under reduced pressure. The crude product was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 5:1, V / V) to obtain 46.9 mg of the seven-membered oxygen-bridged ring product, with a separation yield of 62%.
[0039] Example 6
[0040] Synthesis of 1-5a: Synthesis of ethyl(5R)-6-benzoyl-5-hydroxy-7-phenyl-8-oxabicyclo[3.2.1]oct-6-ene-1-carboxylic acid ester.
[0041] (1-5a) A seven-membered ring substrate (0.2 mmol), Solvent Red 43 (0.01 mmol, 5%), sodium carbonate (0.1 mmol), and anhydrous acetonitrile (2 mL) were added to a dry reaction tube. The reaction was irradiated with a 455 nm blue light (250 V, 4 A) LED and stirred at room temperature (20-25 °C) for 12 h. After the reaction was complete as monitored by TLC, the solvent was removed by rotary evaporation under reduced pressure. The crude product was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 5:1, V / V) to obtain 52.2 mg of the seven-membered oxygen-bridged ring product, with a separation yield of 69%.
[0042] Comparative Example 1 The preparation conditions and methods were the same as in Example 1, except that Solvent Red was not added in Comparative Example 1. The reaction was barely observed by TLC.
[0043] Comparative Example 2 The preparation conditions and methods were the same as in Example 6, except that sodium carbonate was not added in Comparative Example 2. The reaction was barely observed by TLC.
[0044] Example 7
[0045] Synthesis of 1-5b: Synthesis of ethyl 5-hydroxy-6-(4-methylbenzoyl)-7-phenyl-8-oxabicyclo[3.2.1]oct-6-ene-1-carboxylic acid ester.
[0046] (1-5b) A seven-membered ring substrate (0.2 mmol), Solvent Red 43 (0.01 mmol, 5%), sodium carbonate (0.2 mmol), and anhydrous acetonitrile (2 mL) were added to a dry reaction tube. The reaction was irradiated with a 455 nm blue light (250 V, 4 A) LED and stirred at room temperature (20-25 °C) for 12 h. After the reaction was complete as monitored by TLC, the solvent was removed by rotary evaporation under reduced pressure. The crude product was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 5:1, V / V) to obtain 47.5 mg of the seven-membered oxygen-bridged ring product, with a separation yield of 60%.
[0047] NMR data: 1 H NMR (400 MHz, CDCl3) δ 1.11-1.16 (t, J = 10 Hz, 3H), 1.85-1.98 (m, 5H), 2.13-2.16 (m, 1H), 2.28 (s, 3H), 4.14-4.27 (m, 2H), 7.01-7.06(m, 4H), 7.09-7.16 (m, 3H), 7.68-7.71 (m, 2H); 13 C NMR (100 MHz, CDCl3) δ192.4, 168.4, 145.1, 143.6, 138.0, 132.7, 129.9, 128.7, 128.0, 127.9, 127.3,127.0, 108.0, 87.4, 60.7, 29.1, 24.7, 20.6, 18.0, 12.9. Example 8
[0048] Synthesis of 1-5c: Synthesis of ethyl-5-hydroxy-6-(4-methoxybenzoyl)-7-phenyl-8-oxabicyclo[3.2.1]oct-6-ene-1-carboxylic acid ester.
[0049] (1-5c) A seven-membered ring substrate (0.2 mmol), Solvent Red 43 (0.01 mmol, 5%), sodium carbonate (0.2 mmol), and anhydrous acetonitrile (2 mL) were added to a dry reaction tube. The reaction was irradiated with a 455 nm blue light (250 V, 4 A) LED and stirred at room temperature (20-25 °C) for 12 h. After the reaction was complete as monitored by TLC, the solvent was removed by rotary evaporation under reduced pressure. The crude product was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 5:1, V / V) to obtain 61.3 mg of the seven-membered oxygen-bridged ring product, with a separation yield of 75%.
[0050] NMR data: 1 H NMR (400 MHz, CDCl3) δ 1.11-1.15 (t, J = 8 Hz, 3H), 1.86-1.97 (m, 5H), 2.13-2.16 (m, 1H), 3.76 (s, 3H), 4.14-4.27 (m, 2H), 6.67-6.71(m, 2H), 7.03-7.07 (m, 2H), 7.10-7.16 (m, 3H), 7.75-7.76 (m, 2H); 13 C NMR (100MHz, CDCl3) δ 192.2, 169.5, 164.0, 145.6, 139.0, 132.0, 131.0, 129.2, 129.0,128.3, 128.0, 113.6, 109.1, 88.4, 61.7, 55.4, 30.1, 25.8, 19.1, 13.9. Example 9
[0051] Synthesis of 1-5d: Synthesis of ethyl-6-(3-bromobenzoyl)-5-hydroxy-7-phenyl-8-oxabicyclo[3.2.1]oct-6-ene-1-carboxylic acid ester.
[0052] (1-5d) A seven-membered ring substrate (0.2 mmol), Solvent Red 43 (0.01 mmol, 5%), sodium carbonate (0.2 mmol), and anhydrous acetonitrile (2 mL) were added to a dry reaction tube. The reaction was irradiated with a 455 nm blue light (250 V, 4 A) LED and stirred at room temperature (20-25 °C) for 12 h. After the reaction was complete as monitored by TLC, the solvent was removed by rotary evaporation under reduced pressure. The crude product was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 5:1, V / V) to obtain 64.0 mg of the seven-membered oxygen-bridged ring product, with a separation yield of 70%.
[0053] NMR data: 1 H NMR (400 MHz, CDCl3) δ 1.16-1.20 (t, J = 8 Hz, 3H), 1.78-2.01 (m, 5H), 2.25-2.29 (m, 1H), 4.15-4.31 (m, 2H), 6.96-7.15 (m, 6H), 7.40-7.43 (m, 1H), 7.63-7.66 (m, 1H), 7.83-7.84 (m, 1H);13 C NMR (100 MHz, CDCl3) δ192.2, 169.3, 148.9, 139.0, 137.9, 136.0, 132.4, 130.6, 129.7, 129.3, 128.4,128.1, 128.0, 122.3, 109.3, 88.7, 61.9, 30.3, 25.2, 19.1, 13.9. Example 10
[0054] Synthesis of 1-5e: Synthesis of ethyl-5-hydroxy-6-(2-nitrobenzoyl)-7-phenyl-8-oxabicyclo[3.2.1]oct-6-ene-1-carboxylic acid ester.
[0055] (1-5e) A seven-membered ring substrate (0.2 mmol), Solvent Red 43 (0.01 mmol, 5%), sodium carbonate (0.2 mmol), and anhydrous acetonitrile (2 mL) were added to a dry reaction tube. The reaction was irradiated with a 455 nm blue light (250 V, 4 A) LED and stirred at room temperature (20-25 °C) for 12 h. After the reaction was complete as monitored by TLC, the solvent was removed by rotary evaporation under reduced pressure. The crude product was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 5:1, V / V) to obtain 57.6 mg of the seven-membered oxygen-bridged ring product, with a separation yield of 68%.
[0056] NMR data: 1 H NMR (400 MHz, CDCl3) δ 0.92-0.96 (t, J = 7 Hz, 3H), 2.43-2.50 (m, 4H), 2.86-2.90 (m, 2H), 3.97-4.02 (m, 2H), 7.21-7.24 (m, 3H), 7.27-7.29 (m, 2H), 7.32-7.36 (m, 1H), 7.46-7.48 (m, 1H), 7.62-7.67 (m, 1H), 8.06-8.09 (m, 1H); 13 C NMR (100 MHz, CDCl3) δ 175.2, 169.9, 155.9, 142.6, 139.6,134.1, 133.4, 127.8, 127.7, 127.6, 126.3, 125.2, 124.3, 121.0, 117.9, 60.7,34.7, 30.6, 28.3, 13.6. Example 11
[0057] Synthesis of 1-5f: Synthesis of ethyl-6-benzoyl-5-hydroxy-7-(p-tolyl)-8-oxabicyclo[3.2.1]oct-6-ene-1-carboxylic acid ester.
[0058] (1-5f) A seven-membered ring substrate (0.2 mmol), Solvent Red 43 (0.01 mmol, 5%), sodium carbonate (0.2 mmol), and anhydrous acetonitrile (2 mL) were added to a dry reaction tube. The reaction was irradiated with a 455 nm blue light (250 V, 4 A) LED and stirred at room temperature (20-25 °C) for 12 h. After the reaction was complete as monitored by TLC, the solvent was removed by rotary evaporation under reduced pressure. The crude product was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 5:1, V / V) to obtain 54.2 mg of the seven-membered oxygen-bridged ring product, with a separation yield of 69%.
[0059] NMR data: 1 H NMR (400 MHz, CDCl3) δ 1.16-1.20 (t, J = 8 Hz, 3H), 1.61(s, 1H), 1.85-1.98 (m, 5H), 2.19 (s, 3H), 4.17-4.29 (m, 2H), 6.90 (s, 4H),7.21-7.25 (m, 2H), 7.35-7.41 (m, 1H), 7.77-7.80 (m, 2H); 13 C NMR (100 MHz, CDCl3) δ 193.7, 169.4, 136.2, 133.4, 129.5, 129.0, 128.3, 128.0, 127.7, 109.0, 88.5, 61.8, 31.4, 30.2, 21.2, 19.0, 14.0. Example 12
[0060] Synthesis of 1-5g: Synthesis of ethyl-6-benzoyl-7-(4-bromophenyl)-5-hydroxy-8-oxabicyclo[3.2.1]oct-6-ene-1-carboxylic acid ester.
[0061] (1-5g) A seven-membered ring substrate (0.2 mmol), Solvent Red 43 (0.01 mmol, 5%), sodium carbonate (0.2 mmol), and anhydrous acetonitrile (2 mL) were added to a dry reaction tube. The reaction was irradiated with a 455 nm blue light (250 V, 4 A) LED and stirred at room temperature (20-25 °C) for 12 h. After the reaction was complete as monitored by TLC, the solvent was removed by rotary evaporation under reduced pressure. The crude product was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 5:1, V / V) to obtain 66.8 mg of the seven-membered oxygen-bridged ring product, with a separation yield of 73%.
[0062] NMR data: 1 H NMR (400 MHz, CDCl3) δ 1.14-1.18 (t, J = 8 Hz, 3H), 1.86-1.99 (m, 5H), 2.19-2.21 (m, 1H), 4.16-4.29 (m, 2H), 6.79-6.82 (m, 2H), 6.91-6.93 (m, 1H), 6.96-7.01 (m, 1H), 7.18-7.23 (m, 2H), 7.33-7.38 (m, 1H), 7.74-7.77 (m, 2H); 13 C NMR (100 MHz, CDCl3) δ 194.0, 169.4, 147.6, 137.8, 136.4,133.3, 130.6, 129.8, 129.4, 128.9, 128.2, 128.1, 125.1, 109.1, 88.5, 61.8,30.2, 29.7, 19.1, 13.9. Example 13
[0063] Synthesis of 1-5h: Synthesis of ethyl-6-benzoyl-7-(3-fluorophenyl)-5-hydroxy-8-oxabicyclo[3.2.1]oct-6-ene-1-carboxylic acid ester.
[0064] (1-5 hours) A seven-membered ring substrate (0.2 mmol), Solvent Red 43 (0.01 mmol, 5%), sodium carbonate (0.2 mmol), and anhydrous acetonitrile (2 mL) were added to a dry reaction tube. The reaction was irradiated with a 455 nm blue light (250 V, 4 A) LED and stirred at room temperature (20-25 °C) for 12 h. After the reaction was complete as monitored by TLC, the solvent was removed by rotary evaporation under reduced pressure. The crude product was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 5:1, V / V) to obtain 53.9 mg of the seven-membered oxygen-bridged ring product, with a separation yield of 68%.
[0065] NMR data: 1 H NMR (400 MHz, CDCl3) δ 1.14-1.18 (t, J = 8 Hz, 3H), 1.87-2.01 (m, 5H), 2.18-2.21 (m, 1H), 4.16-4.27 (m, 2H), 6.72-6.86 (m, 3H), 7.04-7.10 (m, 1H), 7.23-7.27 (m, 2H), 7.37-7.42 (m, 1H), 7.77-7.79 (m, 2H); 13 C NMR(100 MHz, CDCl3) δ 193.5, 169.1, 163.4, 161.0, 145.3, 145.3, 140.3, 136.2,133.7, 132.9, 132.8, 130.0, 130.0, 129.5, 128.4, 124.0, 124.0, 116.1, 115.9,115.2, 114.9, 109.2, 88.5, 61.9, 30.1, 25.6, 19.0, 13.9. Example 14
[0066] Synthesis of 1-5i: Synthesis of ethyl 6-(4-bromobenzoyl)-5-hydroxy-7-phenyl-8-oxabicyclo[3.2.1]oct-6-ene-1-carboxylic acid ester.
[0067] (1-5i) A seven-membered ring substrate (0.2 mmol), Solvent Red 43 (0.01 mmol, 5%), sodium carbonate (0.2 mmol), and anhydrous acetonitrile (2 mL) were added to a dry reaction tube. The reaction was irradiated with a 455 nm blue light (250 V, 4 A) LED and stirred at room temperature (20-25 °C) for 12 h. After the reaction was complete as monitored by TLC, the solvent was removed by rotary evaporation under reduced pressure. The crude product was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 5:1, V / V) to obtain 64.9 mg of the seven-membered oxygen-bridged ring product, with a separation yield of 71%.
[0068] NMR data: 1 H NMR (400 MHz, CDCl3) δ 1.15-1.19 (t, J = 8 Hz, 3H), 1.83-1.99 (m, 5H), 2.23-2.26 (m, 1H), 4.17-4.28 (m, 2H), 6.97-6.99 (m, 2H), 7.10-7.18 (m, 3H), 7.29-7.31 (m, 2H), 7.56-7.61 (m, 2H); 13 C NMR (100 MHz, CDCl3) δ192.8, 169.5, 147.7, 139.2, 135.0, 131.5, 131.0, 130.5, 129.4, 128.7, 128.4,128.3, 128.1, 127.1, 109.4, 88.6, 62.0, 31.9, 31.4, 14.1, 13.9. Example 15
[0069] Synthesis of 1-5j: Synthesis of ethyl 6-(4-chlorobenzoyl)-5-hydroxy-7-phenyl-8-oxabicyclo[3.2.1]oct-6-ene-1-carboxylic acid ester.
[0070] (1-5j) A seven-membered ring substrate (0.2 mmol), Solvent Red 43 (0.01 mmol, 5%), sodium carbonate (0.2 mmol), and anhydrous acetonitrile (2 mL) were added to a dry reaction tube. The reaction was irradiated with a 455 nm blue light (250 V, 4 A) LED and stirred at room temperature (20-25 °C) for 12 h. After the reaction was complete as monitored by TLC, the solvent was removed by rotary evaporation under reduced pressure. The crude product was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 5:1, V / V) to obtain 57.8 mg of the seven-membered oxygen-bridged ring product, with a separation yield of 70%.
[0071] NMR data: 1 H NMR (400 MHz, CDCl3) δ 1.15-1.19 (t, J = 8 Hz, 3H), 1.80-1.97 (m, 5H), 2.26-2.31 (m, 1H), 4.16-4.28 (m, 2H), 6.96-6.99 (m, 2H), 7.08-7.15 (m, 5H), 7.66-7.69 (m, 2H); 13 C NMR (100 MHz, CDCl3) δ 192.6, 169.6,147.6, 139.7, 139.3, 134.6, 130.9, 130.5, 129.5, 129.4, 128.6, 128.4, 128.4,128.1, 127.8, 119.2, 109.5, 88.6, 62.0, 30.3, 25.2, 19.0, 13.9. Example 16
[0072] Synthesis of 1-5k: Synthesis of ethyl 6-benzoyl-5-hydroxy-7-(m-tolyl)-8-oxabicyclo[3.2.1]oct-6-ene-1-carboxylic acid ester.
[0073] (1-5k) A seven-membered ring substrate (0.2 mmol), Solvent Red 43 (0.01 mmol, 5%), sodium carbonate (0.2 mmol), and anhydrous acetonitrile (2 mL) were added to a dry reaction tube. The reaction was irradiated with a 455 nm blue light (250 V, 4 A) LED and stirred at room temperature (20-25 °C) for 12 h. After the reaction was complete as monitored by TLC, the solvent was removed by rotary evaporation under reduced pressure. The crude product was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 5:1, V / V) to obtain 51.8 mg of the seven-membered oxygen-bridged ring product, with a separation yield of 66%.
[0074] NMR data: 1H NMR (400 MHz, CDCl3) δ 1.14-1.18 (t, J = 8 Hz, 3H), 1.86-1.99 (m, 5H), 2.12 (s, 3H), 2.17-2.20 (m, 1H), 4.16-4.28 (m, 2H), 6.79-6.83(m, 2H), 6.91-6.94 (m, 1H), 6.96-6.99 (m, 1H), 7.19-7.24 (m, 2H), 7.34-7.39(m, 1H), 7.74-7.77 (m, 2H); 13 C NMR (100 MHz, CDCl3) δ 193.9, 169.3, 147.7,138.6, 137.9, 136.4, 133.4, 130.6, 129.8, 129.4, 128.8, 128.2, 128.1, 125.1,109.0, 88.5, 61.8, 30.2, 25.6, 21.1, 19.1, 13.9. The above description is merely a preferred embodiment of the present invention and is not intended to limit the present invention in any way. Although the present invention has been disclosed above with reference to preferred embodiments, it is not intended to limit the present invention. Any person skilled in the art can make some modifications or alterations to the above-disclosed technical content to create equivalent embodiments without departing from the scope of the present invention. Any simple modifications, equivalent changes, and alterations made to the above embodiments based on the technical essence of the present invention without departing from the scope of the present invention shall still fall within the scope of the present invention.
Claims
1. A method for preparing a seven-membered oxygen-bridged ring compound, characterized in that: The reaction process is shown in equation (I). (I) Wherein, R1 is hydrogen, methoxy, nitro, bromine or methyl; R2 is hydrogen, chlorine, fluorine or methyl; The preparation method includes the following steps: Step 1: Add the seven-membered ring substrate, Solvent Red catalyst, and base auxiliary agent to the reaction vessel, and add the reaction solvent to the reaction system to dissolve the reactants; Step 2: The reaction system is stirred under visible light irradiation; Step 3: After the reaction is complete, the reaction solution is concentrated and separated by column chromatography to obtain the seven-membered oxygen-bridged ring product.
2. The preparation method according to claim 1, characterized in that: The seven-membered ring substrate is a seven-membered ring with an electron-withdrawing group or a seven-membered ring with an electron-donating group.
3. The preparation method according to claim 1, characterized in that: The alkali additive is one of K2CO3, Cs2CO3, Na2CO3 or CsF.
4. The preparation method according to claim 1, characterized in that: The reaction solvent is one of N,N-dimethylformamide, N,N-dimethylacetamide, dimethyl sulfoxide, or acetonitrile.
5. The preparation method according to claim 1, characterized in that: The molar ratio of seven-membered ring substrate: base promoter: solvent red catalyst is 1:(0.5~2):0.
05.
6. The preparation method according to claim 1, characterized in that: In step two, the light is irradiated under 455 nm blue light conditions.
7. A seven-membered oxygen-bridged ring compound, characterized in that: Its structural formula is shown in equation (II) below: (Ⅱ) Wherein, R1 is hydrogen, methoxy, nitro, bromine or methyl; R2 is hydrogen, chlorine, fluorine or methyl.
8. A seven-membered oxygen-bridged ring compound according to claim 7, characterized in that: Its structural formula is selected from one of the following: ; ; ; ; ; ; ; ; ; ; 。
